Journal of Gastrointestinal Oncology

Papers
(The TQCC of Journal of Gastrointestinal Oncology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management67
The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma60
Neoadjuvant therapy in locally advanced colon cancer: a meta-analysis and systematic review46
Exosomal miR-30a and miR-222 derived from colon cancer mesenchymal stem cells promote the tumorigenicity of colon cancer through targeting MIA329
Application of photodynamic therapy for liver malignancies27
Exosomal miR-142-3p secreted by hepatitis B virus (HBV)-hepatocellular carcinoma (HCC) cells promotes ferroptosis of M1-type macrophages through SLC3A2 and the mechanism of HCC progression27
The inhibitory effects of probiotics on colon cancer cells: in vitro and in vivo studies27
Role of yttrium-90 selective internal radiation therapy in the treatment of liver-dominant metastatic colorectal cancer: an evidence-based expert consensus algorithm24
Surgical management of recurrent colon cancer24
Enhanced fatty acid oxidation mediated by CPT1C promotes gastric cancer progression24
Comparison of efficacy and safety between pembrolizumab combined with chemotherapy and simple chemotherapy in neoadjuvant therapy for esophageal squamous cell carcinoma21
Application of serum pepsinogen and carbohydrate antigen 72-4 (CA72-4) combined with gastrin-17 (G-17) detection in the screening, diagnosis, and evaluation of early gastric cancer21
Preoperative computed tomography-assessed skeletal muscle index is a novel prognostic factor in patients with hepatocellular carcinoma following hepatectomy: a meta-analysis20
Toripalimab combined with docetaxel and cisplatin neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: a single-center, single-arm clinical trial (ESONICT-2)20
Highly expressed Claudin18.2 as a potential therapeutic target in advanced gastric signet-ring cell carcinoma (SRCC)20
Inherited syndromes involving pancreatic neuroendocrine tumors19
Intracorporeal anastomosis versus extracorporeal anastomosis for minimally invasive colectomy18
Surgical management of pancreatic neuroendocrine liver metastases18
Pancreatic neuroendocrine neoplasms: current state and ongoing controversies on terminology, classification and prognostication18
Prognostic value of systemic immune-inflammatory index in survival outcome in gastric cancer: a meta-analysis17
CircTBL1XR1/miR-424 axis regulates Smad7 to promote the proliferation and metastasis of colorectal cancer16
Hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases: lessons learned from PRODIGE 716
Microwave ablation for colorectal cancer metastasis to the liver: a single-center retrospective analysis16
Genetic and epigenetic alterations in pancreatic neuroendocrine tumors15
Omics analyses in peritoneal metastasis—utility in the management of peritoneal metastases from colorectal cancer and pseudomyxoma peritonei: a narrative review15
Liver transplantation in the treatment of unresectable hepatic metastasis from neuroendocrine tumors15
Intraperitoneal paclitaxel: pharmacology, clinical results and future prospects14
PD-L1 immunohistochemistry comparison of 22C3 and 28-8 assays for gastric cancer14
Expression and prognostic value of Chromobox family members in gastric cancer14
Identification of gene signatures and potential therapeutic targets for acquired chemotherapy resistance in gastric cancer patients13
miR-133a-5p suppresses gastric cancer through TCF4 down-regulation13
Clinicopathological and prognostic significance of programmed death ligant-1 expression in gastric cancer: a meta-analysis13
Value of nutrition support therapy in patients with gastrointestinal malignancies: a narrative review and health economic analysis of impact on clinical outcomes in the United States13
Intraperitoneal chemotherapy in the treatment of gastric cancer peritoneal metastases: an overview of common therapeutic regimens13
Circulating tumor DNA as a potential prognostic and predictive biomarker during interventional therapy of unresectable primary liver cancer13
Current status of laparoscopic liver resection for the management of colorectal liver metastases13
Conversion surgery in patients with pancreatic cancer and peritoneal metastasis13
Efficacy and tolerability of the combination of nano-liposomal irinotecan and 5-fluorouracil/leucovorin in advanced pancreatic adenocarcinoma: post-approval clinic experience13
Impact of radiotherapy duration on overall survival in squamous cell carcinoma of the anus13
A review of systemic therapy in biliary tract carcinoma12
Esophageal cancer: the rise of adenocarcinoma over squamous cell carcinoma in the Asian belt12
Combined endo-laparoscopic surgery for difficult benign colorectal polyps12
The emergence of pressurized intraperitoneal aerosol chemotherapy as a palliative treatment option for patients with diffuse peritoneal metastases: a narrative review12
Prognostic value and association of sarcopenic obesity and systemic inflammatory indexes in patients with hepatocellular carcinoma following hepatectomy and the establishment of novel predictive nomog12
Machine learning-based random forest predicts anastomotic leakage after anterior resection for rectal cancer12
Differential analysis of RNA methylation regulators in gastric cancer based on TCGA data set and construction of a prognostic model12
Morphine promotes angiogenesis by activating PI3K/Akt/HIF-1α pathway and upregulating VEGF in hepatocellular carcinoma12
Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) in patients with colorectal peritoneal metastases—a systematic review12
Minimally invasive surgery in the geriatric patient with colon cancer12
Asiaticoside inhibits epithelial-mesenchymal transition and stem cell-like properties of pancreatic cancer PANC-1 cells by blocking the activation of p65 and p38MAPK12
Development and validation of a Surveillance, Epidemiology, and End Results (SEER)-based prognostic nomogram for predicting survival in elderly patients with gastric cancer after surgery12
High expression of aldolase A is associated with tumor progression and poor prognosis in hepatocellular carcinoma11
Pathologic complete response (pCR) rates and outcomes after neoadjuvant chemoradiotherapy with proton or photon radiation for adenocarcinomas of the esophagus and gastroesophageal junction11
CXCL5/CXCL8 is a promising potential prognostic and tumor microenvironment-related cluster in hepatocellular carcinoma11
Cause of death for elders with colorectal cancer: a real-world data analysis11
Survival benefits of palliative gastrectomy in stage IV gastric cancer: a propensity score matched analysis11
CircBACH1/let-7a-5p axis enhances the proliferation and metastasis of colorectal cancer by upregulating CREB5 expression11
Value of multiphase contrast-enhanced CT with three-dimensional reconstruction in detecting depth of infiltration, lymph node metastasis, and extramural vascular invasion of gastric cancer11
Intraperitoneal chemotherapy for ovarian cancer with peritoneal metastases, systematic review of the literature and focused personal experience11
Favorable tumor biology in locally advanced pancreatic cancer—beyond CA19-911
Colorectal cancer surgery in elderly patients 80 years and older: a comparison with younger age groups11
Stereotactic body radiation therapy versus radiofrequency ablation for single small hepatocellular carcinoma: a propensity-score matching analysis of their impact on liver function and clinical outcom11
Pathology reporting of margin status in locally advanced pancreatic cancer: challenges and uncertainties11
Selecting surgical candidates with locally advanced pancreatic cancer: a review for modern pancreatology11
Evaluating treatment protocols for rectal squamous cell carcinomas: the Duke experience and literature11
Specific genomic alterations and prognostic analysis of perihilar cholangiocarcinoma and distal cholangiocarcinoma11
Factors associated with worse outcomes for colorectal neuroendocrine tumors in radical versus local resections11
Candidate oncogene circularNOP10 mediates gastric cancer progression by regulating miR-204/SIRT1 pathway10
Surgical resection of metastatic pancreatic cancer: is it worth it?—a 15-year experience at a single Chinese center10
Discovery of a novel three-long non-coding RNA signature for predicting the prognosis of patients with gastric cancer10
A novel robust nomogram based on preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) for predicting lymph node metastasis of gastric cancer10
Comprehensive analysis of the prognosis for chromobox family in gastric cancer10
Evaluating the effect of diabetes on the prognosis of gastric cancer using a propensity score matching method10
Mitofusin-2 is a novel anti-angiogenic factor in pancreatic cancer10
Prognostic significance of controlling nutritional status score- based nomogram for hepatocellular carcinoma within Milan criteria after radiofrequency ablation10
Prognostic implications of mucinous histology in stage III colon cancer with the receipt of adjuvant chemotherapy10
Correlation between Claudin-18 expression and clinicopathological features and prognosis in patients with gastric cancer10
The expression and prognostic value of GLYATL1 and its potential role in hepatocellular carcinoma10
Evaluation of confocal laser endomicroscopy for detection of occult gastric carcinoma in CDH1 variant carriers9
Relationship between IL-10 and PD-L1 in esophageal carcinoma tissues and IL-10 down-regulates PD-L1 expression via Met signaling pathway9
The use of neoadjuvant lobar radioembolization prior to major hepatic resection for malignancy results in a low rate of post hepatectomy liver failure9
Targeting CA 19-9 with a humanized monoclonal antibody at the time of surgery may decrease recurrence rates for patients undergoing resections for pancreatic cancer, cholangiocarcinoma and metastatic 9
Decreased albumin-to-alkaline phosphatase ratio predicted poor survival of resectable gastric cancer patients9
Effects of YAP1 and SFRP2 overexpression on the biological behavior of colorectal cancer cells and their molecular mechanisms9
Crocin reverses 1-methyl-3-nitroso-1-nitroguanidine (MNNG)-induced malignant transformation in GES-1 cells through the Nrf2/Hippo signaling pathway9
Upregulation of ERCC6L is associated with tumor progression and unfavorable prognosis in hepatocellular carcinoma9
Qingjie Fuzheng Granules regulates cancer cell proliferation, apoptosis and tumor angiogenesis in colorectal cancer xenograft mice via Sonic Hedgehog pathway9
Jejunostomy at the time of esophagectomy is associated with improved short-term perioperative outcomes: analysis of the NSQIP database9
Circulating TGF-β1 as the potential epithelial mesenchymal transition-biomarker for diagnosis of cholangiocarcinoma9
Implications of the growing incidence of global colorectal cancer9
Short-term outcomes of laparoscopic versus open total gastrectomy after neoadjuvant chemotherapy: a cohort study using the propensity score matching method9
Clinical efficacy and safety of 3D vascular reconstruction combined with 3D navigation in laparoscopic hepatectomy: systematic review and meta-analysis9
Incidence and detection of high microsatellite instability in colorectal cancer in a Chinese population: a meta-analysis8
Social determinants of health associated with poor outcome for rural patients following resected pancreatic cancer8
Clinical efficacy and quality of life after transrectal natural orifice specimen extraction for the treatment of middle and upper rectal cancer8
Propofol activates AMPK to inhibit the growth of HepG2 cells in vitro and hepatocarcinogenesis in xenograft mouse tumor models by inducing autophagy8
Long non-coding RNA small nucleolar RNA host gene 7 facilitates the proliferation, migration, and invasion of esophageal cancer cells by regulating microRNA-6258
miR-744-5p suppresses tumor proliferation and metastasis by targeting transforming growth factor-beta 1 (TGF-β1) in hepatocellular carcinoma (HCC)8
Comprehensive literature review of randomized clinical trials examining novel treatment advances in patients with colon cancer8
The prognostic role of neutrophil-to-lymphocyte ratio and C-reactive protein in metastatic colorectal cancer using regorafenib: a systematic review and meta-analysis8
Short and long-term outcomes after proximal gastrectomy with double tract reconstruction for Siewert type III adenocarcinoma of the esophagogastric junction: a propensity score matching study from a 18
Association of social determinants of health with late diagnosis and survival of patients with pancreatic cancer8
Postoperative adjuvant transarterial chemoembolization for intrahepatic cholangiocarcinoma patients with microvascular invasion: a propensity score analysis8
Prognostic significance of systemic immune-inflammation index- based nomogram for early stage hepatocellular carcinoma after radiofrequency ablation8
Prognostic performance of different lymph node classification systems in young gastric cancer8
Hsa_circ_NOTCH3 regulates ZNF146 through sponge adsorption of miR-875-5p to promote tumorigenesis of hepatocellular carcinoma8
Combination of preoperative red cell distribution width and neutrophil to lymphocyte ratio as a prognostic marker for gastric cancer patients8
Intraperitoneal gemcitabine chemotherapy is safe for patients with resected pancreatic cancer: final clinical and pharmacologic data from a phase II protocol and recommended future directions8
New insights in the pathology of peritoneal surface malignancy8
Investigating disparities: the effect of social environment on pancreatic cancer survival in metastatic patients8
Increased expression of MCM4 is associated with poor prognosis in patients with hepatocellular carcinoma8
Genome variation in colorectal cancer patient with liver metastasis measured by whole-exome sequencing8
Effects of molecular markers on the treatment decision and prognosis of colorectal cancer: a narrative review8
Intra-operative hyperthermic intraperitoneal chemotherapy for prevention and treatment of peritoneal metastases from gastric cancer: a narrative review8
Real world aspects of palliative trifluridine plus tiperacil (TAS-102) in refractory metastatic colorectal cancer8
Utility of feeding jejunostomy in patients with esophageal cancer undergoing esophagectomy with a high risk of anastomotic leakage8
Hyperthermic intraperitoneal chemotherapy in prevention of gastric cancer metachronous peritoneal metastases: a systematic review8
Comparison of transcatheter arterial chemoembolization with raltitrexed plus liposomal doxorubicin vs. tegafur plus pirarubicin for unresectable hepatocellular carcinoma8
Abrogation of ARF6 in promoting erastin-induced ferroptosis and mitigating capecitabine resistance in gastric cancer cells8
Estimating the prognosis of esophageal squamous cell carcinoma based on The Cancer Genome Atlas (TCGA) of m6A methylation-associated genes8
Impact of perioperative intravenous lidocaine infusion on postoperative pain and rapid recovery of patients undergoing gastrointestinal tumor surgery: a randomized, double-blind trial8
Extent of venous resection during pancreatectomy—finding the balance of technical possibility and feasibility8
Chemoradiotherapy for patients with locally advanced or unresectable extra-hepatic biliary cancer7
Molecular characterization of squamous cell carcinoma of the anal canal7
CD276 suppresses CAR-T cell function by promoting tumor cell glycolysis in esophageal squamous cell carcinoma7
Yes-activated protein promotes primary resistance of BRAF V600E mutant metastatic colorectal cancer cells to mitogen-activated protein kinase pathway inhibitors7
Inhibition of ITGB1-DT expression delays the growth and migration of stomach adenocarcinoma and improves the prognosis of cancer patients using the bioinformatics and cell model analysis7
The incidence, risk factors and predictive nomograms for early death among patients with stage IV gastric cancer: a population-based study7
Ramucirumab plus paclitaxel or FOLFIRI in platinum-refractory advanced or metastatic gastric or gastroesophageal junction adenocarcinoma—experience at two centres7
BRAF-V600E and microsatellite instability prediction through CA-19-9/CEA ratio in patients with colorectal cancer7
A retrospective study of clinicopathological characteristics and prognostic factors of Krukenberg tumor with gastric origin7
Prognosis model of colorectal cancer patients based on NOTCH3, KMT2C, and CREBBP mutations7
Bioinformatical identification of key genes regulated by IGF2BP2- mediated RNA N6-methyladenosine and prediction of prognosis in hepatocellular carcinoma7
Development and verification of a hypoxia- and immune-associated prognosis signature for esophageal squamous cell carcinoma7
Global trends in pancreas cancer among Asia-Pacific population7
A narrative review of systemic treatment options for hepatocellular carcinoma: state of the art review7
Study on safety and efficacy of regorafenib combined with transcatheter arterial chemoembolization in the treatment of advanced hepatocellular carcinoma after first-line targeted therapy7
Combination of the ratio between metastatic and harvested lymph nodes and negative lymph node count as a prognostic indicator in advanced gastric cancer: a retrospective cohort study7
Correlation analysis of tumor mutation burden of hepatocellular carcinoma based on data mining7
Collagen XV mediated the epithelial-mesenchymal transition to inhibit hepatocellular carcinoma metastasis7
Efficacy and safety of camrelizumab in combination with trastuzumab and chemotherapy as the first-line treatment for patients with HER2-positive advanced gastric cancer7
N-myc downstream-regulated gene 2 promotes the protein stability of estrogen receptor beta via inhibition of ubiquitin-protein ligase E3A to suppress colorectal cancer7
Genome-wide association study of the TP53 R249S mutation in hepatocellular carcinoma with aflatoxin B1 exposure and infection with hepatitis B virus7
Review of management and treatment of peritoneal metastases from gastric cancer origin7
LncRNA-CASC7 inhibits the proliferation and migration of colon cancer by negatively regulating the PI3K/Akt signaling pathway7
Immune checkpoint inhibitors in liver transplant: a case series7
Expression characteristics of long non-coding RNA in colon adenocarcinoma and its potential value for judging the survival and prognosis of patients: bioinformatics analysis based on The Cancer Genome7
Identification and validation of xenobiotic metabolism-associated prognostic signature based on five genes to evaluate immune microenvironment in colon cancer7
A prospective trial of stereotactic body radiation therapy for unresectable pancreatic cancer testing ablative doses7
Colorectal cancer in pregnancy: a case report and literature review7
Comprehensive analysis of the relationship between competitive endogenous RNA (ceRNA) networks and tumor infiltrating-cells in hepatocellular carcinoma6
A signature of Prevotella copri and Faecalibacterium prausnitzii depletion, and a link with bacterial glutamate degradation in the Kenyan colorectal cancer patients6
Magnetic resonance imaging for preoperative staging of pancreatic cancer based on the 8th edition of AJCC guidelines6
Colon cancer-associated transcript-1 enhances glucose metabolism and colon cancer cell activity in a high-glucose environment in vitro and in vivo6
N6-methyladenosine (m6A) regulatory gene divides hepatocellular carcinoma into three subtypes6
Circulating tumor DNA and plasma microsatellite instability during PD-1 blockade6
Ablative radiation therapy for hepatocellular carcinoma is associated with reduced treatment- and tumor-related liver failure and improved survival6
miRNA-320 inhibits colitis-associated colorectal cancer by regulating the IL-6R/STAT3 pathway in mice6
Prediction of late recurrence after radiofrequency ablation of HBV-related hepatocellular carcinoma with the age-male-albumin-bilirubin-platelets (aMAP) risk score: a multicenter study6
The stress hyperglycemia ratio, a novel index of relative hyperglycemia, predicts short-term mortality in critically ill patients after esophagectomy6
Bee venom protects against pancreatic cancer via inducing cell cycle arrest and apoptosis with suppression of cell migration6
Clinical characteristics and predictors of 5-year survival among colorectal cancer patients in a tertiary hospital in Malaysia6
Efficacy and safety of toripalimab with fruquintinib in the third-line treatment of refractory advanced metastatic colorectal cancer: results of a single-arm, single-center, prospective, phase II clin6
The diagnosis and outcome of Krukenberg tumors6
High neutrophil-to-lymphocyte ratio following stereotactic body radiation therapy is associated with poor clinical outcomes in patients with borderline resectable and locally advanced pancreatic cance6
UBE2C promotes the progression of pancreatic cancer and glycolytic activity via EGFR stabilization-mediated PI3K-Akt pathway activation6
Resectable, borderline, and locally advanced pancreatic cancer—“the good, the bad, and the ugly” candidates for surgery?6
PADI1 contributes to EMT in PAAD by activating the ERK1/2-p38 signaling pathway6
Sarcopenia with systemic inflammation can predict survival in patients with hepatocellular carcinoma undergoing curative resection6
A narrative review of postoperative bleeding in patients with gastric cancer treated with endoscopic submucosal dissection6
Expression and prognostic significance of thrombospondin gene family in gastric cancer6
Diagnostic genes and immune infiltration analysis of colorectal cancer determined by LASSO and SVM machine learning methods: a bioinformatics analysis6
Comprehensive bioinformatics analysis of functional molecules in colorectal cancer6
A discussion of the gut microbiome’s development, determinants, and dysbiosis in cancers of the esophagus and stomach6
Prognostic value and clinicopathological correlation of the tumor regression grade in neoadjuvant chemotherapy for gastric adenocarcinoma: a retrospective cohort study6
Luteolin suppresses the growth of colon cancer cells by inhibiting the IL-6/STAT3 signaling pathway6
Identification of a glycolysis-related gene signature for predicting pancreatic cancer survival6
Estimation of hepatocellular carcinoma mortality using aspartate aminotransferase to platelet ratio index6
Effectiveness of telerehabilitation on short-term quality of life of patients after esophageal cancer surgery during COVID-19: a single-center, randomized, controlled study6
Digestive tract reconstruction of laparoscopic total gastrectomy for gastric cancer: a comparison of the intracorporeal overlap, intracorporeal hand-sewn anastomosis, and extracorporeal anastomosis6
The brain–gut axis in gastrointestinal cancers6
Outcomes of colorectal cancer surgery in nonagenarian patients: a multicenter retrospective study6
Utility of tumor-informed circulating tumor DNA in the clinical management of gastrointestinal malignancies6
Rectal cancer in young patients: incidence and outcome disparities6
LINC00857 promotes the proliferation of pancreatic cancer via MET, STAT3, and CREB6
A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma6
A narrative review of intraperitoneal chemotherapy and cytoreductive surgery (CRS) for peritoneal metastases in gastric cancer6
Factors associated with the refusal of surgery and the associated impact on survival in patients with rectal cancer using the National Cancer Database6
The assessment of intraoperative technique-related risk factors and the treatment of anastomotic leakage after esophagectomy: a narrative review6
Serum calcium improved systemic inflammation marker for predicting survival outcome in rectal cancer6
Proton stereotactic body radiation therapy for liver metastases—results of 5-year experience for 81 hepatic lesions6
Downregulation of Ascl2 promotes cell apoptosis by enhancing autophagy in colorectal cancer cells5
MiR-107 inhibits the malignant biological behavior of esophageal squamous cell carcinoma by targeting TPM35
Bioinformatics analysis of immune infiltrates and tripartite motif (TRIM) family genes in hepatocellular carcinoma5
Prognostic prediction and gene regulation network of EIF2S2 in hepatocellular carcinoma based on data mining5
Comprehensive analysis of the prognostic value of the chemokine-like factor-like MARVEL transmembrane domain-containing family in gastric cancer5
Impact of adjuvant therapy in patients with a microscopically positive margin after resection for gastric and esophageal cancers5
Clinical significance and correlation of miR-200c and P-gp expression in gastric cancer and the effects on multidrug resistance5
Laparoscopic-assisted versus open proximal gastrectomy with double-tract reconstruction for Siewert type II–III adenocarcinomas of esophago-gastric junction: a retrospective observational study of sho5
Liquid biopsies for colorectal cancer: a narrative review of ongoing clinical trials and the current use of this technology at a comprehensive cancer center5
Preoperative serum fibrinogen as a valuable predictor in the nomogram predicting overall survival of postoperative patients with gallbladder cancer5
LRG1 in pancreatic cancer cells promotes inflammatory factor synthesis and the angiogenesis of HUVECs by activating VEGFR signaling5
Increased RBM12 expression predicts poor prognosis in hepatocellular carcinoma based on bioinformatics5
FAT10 promotes hepatocellular carcinoma (HCC) carcinogenesis by mediating P53 degradation and acts as a prognostic indicator of HCC5
Correlation between L3 skeletal muscle index and prognosis of patients with stage IV gastric cancer5
Gastric cancer complicated with hemophagocytic lymphohistiocytosis: case report and a brief review5
Indolent T cell lymphoproliferative disorder of the gastrointestinal tract: an uncommon case with lymph node involvement and the classic Hodgkin’s lymphoma5
Effect of the systemic immune-inflammation index on postoperative complications and the long-term prognosis of patients with colorectal cancer: a retrospective cohort study5
Cost-effectiveness of camrelizumab versus chemotherapy for the treatment of advanced or metastatic esophageal squamous cell carcinoma5
Trichostatin A enhances radiosensitivity and radiation-induced DNA damage of esophageal cancer cells5
The effect of the TP53 and RB1 mutations on the survival of hepatocellular carcinoma patients with different racial backgrounds5
A systematic review and meta-analysis on the efficacy of Compound Kushen Injection in 3 kinds of digestive tract tumor5
Relationship between plasma cell-free DNA (cfDNA) and prognosis of TACE for primary hepatocellular carcinoma5
Curcumin inhibits pancreatic cancer cell proliferation by regulating Beclin1 expression and inhibiting the hypoxia-inducible factor-1α-mediated glycolytic pathway5
Which size is the best cutoff for primary small gastric gastrointestinal stromal tumor?5
Pancreatic INI1-deficient undifferentiated rhabdoid carcinoma achieves complete clinical response on gemcitabine and nab-paclitaxel following immediate progression on FOLFIRINOX: a case report5
c-MYC and HIF1α promoter G-quadruplexes dependent metabolic regulation mechanism of berberine in colon cancer5
Oxaliplatin-based hyperthermic intraperitoneal chemotherapy with single drug versus multiple drug treatment for colorectal cancer with peritoneal metastases: an observational cohort study5
Urokinase plasminogen activator predicts poor prognosis in hepatocellular carcinoma5
The landscape of PD-L1 expression and somatic mutations in hepatocellular carcinoma5
Hypoxia promotes pancreatic cancer cell migration, invasion, and epithelial-mesenchymal transition via modulating the FOXO3a/ DUSP6/ERK axis5
Glypican 1 promotes proliferation and migration in esophagogastric adenocarcinoma via activating AKT/GSK/β-catenin pathway5
Diabetes mellitus and postoperative blood glucose value help predict posthepatectomy liver failure in patients with hepatocellular carcinoma5
High expression of the TEFM gene predicts poor prognosis in hepatocellular carcinoma5
Identification and validation of ferroptosis-associated gene-based on immune score as prognosis markers for hepatocellular carcinoma patients5
Prognostic and immune infiltrates for the Chromobox (CBX) protein family in human pancreatic adenocarcinoma5
STING promotes proliferation and induces drug resistance in colorectal cancer by regulating the AMPK-mTOR pathway5
Chromobox 4 (CBX4) promotes tumor progression and stemness via activating CDC20 in gastric cancer5
Diagnostic and prognostic value of MATN3 expression in gastric carcinoma: TCGA database mining5
The clinical features, management, and survival of elderly patients with colorectal cancer5
Pathobiology, irradiation dosimetric parameters and therapy of radiation-induced gastric damage: a narrative review5
Could CTSK and COL4A2 be specific biomarkers of poor prognosis for patients with gastric cancer in Asia?—a microarray analysis based on regional population5
Incidence and risk factors for sustained hepatic function toxicity 6 months after radioembolization: analysis of the radiation-emitting sir-spheres in non-resectable liver tumor (RESIN) registry5
REXO4 acts as a biomarker and promotes hepatocellular carcinoma progression5
Neoadjuvant intraperitoneal and systemic paclitaxel combined with apatinib and S-1 chemotherapy for conversion therapy in gastric cancer patients with positive exfoliative cytology: a prospective stud5
ACTR3 promotes cell migration and invasion by inducing epithelial mesenchymal transition in pancreatic ductal adenocarcinoma5
High body mass index is associated with an increased overall survival in rectal cancer5
Modified endoscopic full-thickness resection of gastric stromal tumor originating from the muscularis propria layer4
Profiles of immune infiltration in the tumor microenvironment of hepatocellular carcinoma4
Development of a prognostic score for recommended transarterial chemoembolization candidates with spontaneous rupture of hepatocellular carcinoma4
Current management of gastric adenocarcinoma: a narrative review4
Minimally invasive complete mesocolic excision and central vascular ligation (CME/CVL) for right colon cancer4
Screening of a novel autophagy-related prognostic signature and therapeutic targets in hepatocellular carcinoma4
Clinical application of nano-carbon to improve the accuracy of lymph node staging in patients with advanced gastric cancer receiving neoadjuvant chemotherapy: a prospective randomized controlled trial4
Prognostic nomogram for predicting cancer-specific survival in patients with resected hilar cholangiocarcinoma: a large cohort study4
Utility and specificity of plasma heat shock protein 90 alpha, CEA, and CA199 as the diagnostic test in colorectal cancer liver metastasis4
Let food be thy medicine: the role of diet in colorectal cancer: a narrative review4
Prognostic role of myeloid-derived tumor-associated macrophages at the tumor invasive margin in gastric cancer with liver metastasis (GCLM): a single-center retrospective study4
Correlation of ulcerative colitis and colorectal cancer: a systematic review and meta-analysis4
A HER2-mutant patient with late-stage duodenal adenocarcinoma benefited from anti-HER2 therapy and PD-1 inhibition: a case report4
0.077391862869263